Search

Woundcare Products Ligasano epicite hydro Curea Back to products

Exsudate management for malodourous wounds P1 DUO active P2 active Curea P1 DUO active Exudate management, soft debridement and odour reduction with a single wound dressing curea active wound dressings quickly relieve nagging wound odour and thus improve the quality of life for patients and their relatives. In addition, they bind bacteria in a purely physical way and are therefore also excellent for fighting infections. curea P1 duo active fights and neutralises wound odours quickly with its integrated activated charcoal layer. In infected wounds, it also reduces germs through purely physical means, without the risk of developing antimicrobial resistance. Integrated activated charcoal layer for very good odour absorption even in the case of extremely strong wound odours Reduction of the bacterial microbial load in the wound without the risk of microbial resistance and cytotoxicity Cleansing effect with regard to exo- and endotoxins High absorption even under compression and pressure SuperCore® ensures secure binding of excessive exudate Binding and reduction of germs and MMPs Blood binding Soft debridement during dressing changes Reduced risk of wound maceration Core remains stable during application Maintains a balanced, moist wound environment Wear time up to 7 days Indication for use: Slightly to heavily exuding wounds malodorous chronic and acute wounds Infected wounds and wounds at risk of infection IFU P1 Curea P1 DUO active IFU Curea P2 active SuperCore®, activated charcoal and wound spacer grid in one powerful product. Exudate, wound odour, wound infections, and pain during dressing changes are no challenge with curea P2 active and can be treated simultaneously with the wound dressing - without the need for costly sandwich dressings. Document Curea P2 active IFU Back to Curea Back to products

PD Care® The PD Care hip protector is made of a new type of foam. This differs from conventional foam qualities due to its viscoelastic behaviour. The reaction of the protector depends on the force applied: When the force is applied slowly, it shows elastic behaviour; when the force is applied in a shock-like manner (during a fall), it becomes harder and absorbs the impact. The intelligent PD Care hip protector prevents up to 95% of all hip fractures during falls Thanks to these properties, the PD Care hip protectors for seniors can also be worn at night without any problems. In the lying position, the material adapts ideally to the body - when standing up, it regains its original shape within a few seconds The behaviour also changes with temperature - due to body temperature, the foam becomes softer when worn and adapts to the body. Test it: hold the protector under warm running water. Viscoelastic foams have proven to be an effective cushioning material in pressure ulcer prevention for years. Broschüre DE The functional trousers for the hip protectors The PD Care functional underpants are made of high-quality cotton and Lycra. Our Swiss products are characterised by durability and high quality. They can also be worn as incontinence pants (with inserts) Back to products

Fistulas and surgical wounds Texts and images (c) Ligamed Case report 1 - Wound treatment with LIGASANO® for inflamed PEG puncture site Patient data and anamnesis: 2-year old girl from Lower Bavaria, Z.n. epileptic encephalopathy, a PEG plant due to refusal to eat was carried out on 05.09.2016 in Augsburg. First daily bandage change, cleaning with NaCl, supply with Metalline. Inflammation of the injection site, pus focus visible, swollen. Presentation at the paediatrician. Recommendation: Change of dressing twice a day, cleaning with Octenisept, if necessary antiobiotic ointment in case of further deterioration. From 14.09.2016 Start of treatment with LIGASANO®: Cleaning twice daily with Octenisept, application of a sterile LIGASANO® slotted compress 7.5 x 7.5 x 1 cm. Fig. 1: 16.09.2016 cleaning with Octenisept, application of antibiotic ointment for two days, dressing change once a day with LIGASANO® white sterile 7.5 x 7.5 x 1 cm Fig. 2: 23.09.2016 Significant improvement, further dressing change once a day with LIGASANO® white sterile 7.5 x 7.5 x 1 cm, ointment supply ended. Fig. 3: 10.10.2016 Minimal inflammation still present, further dressing change once a day with LIGASANO® white sterile 7.5 x 7.5 x 1 cm Fig. 4: 23.10.2016 complete healing of the inflammation. Fig. 5: 23.10.2016 Further use of the slit compress made of LIGASANO® white sterile 7.5 x 7.5 x 1 cm Conclusion: A very simple, inexpensive and allergen-free supply. The slit compresses made of LIGASANO® white dressing material are still used as pressure protection and prophylaxis. Author: Barbara Hinz, nurse, wound expert, from Landshut, German (c) Ligamed Padding of hoses, catheters and tubes Prefabricated slit compresses Case report 2 - Wound treatment with LIGASANO® for abscessing sinus pilonidalis Patient data / anamnesis: 33 years, male, abscessing sinus pilonidalis (recurrence), condition after excision, open wound treatment in November 2014 with abscess left lateral to the penis root, condition after excision, open wound treatment in April 2013 with abscessing sinus pilonidalis, condition after pit-picking, nicotine abuse. In September 2015 an excision of the abscessing pilonidal sinus was performed. Histological findings: Pilonidal sinus with florid and chronic fibrosing inflammation. Pretreatment in the clinic: Several times daily showering of the wound. Treatment with compresses was performed as wound filler and wound covering. A Fixomull® stretch polyacrylate adhesive plaster was used for fixation. The patient presented for the first time on 27 October 2015 at our WZ® Wound Centre with severe pain in the area of the wound and wound environment under drug pain therapy with Cox-2 inhibitor - Arcoxia 90 mg in the morning. The wound environment showed no signs of irritation. There was a slight bleeding in the area of the wound margin. The wound depth was 2.5 cm up to the subcutis. 80% of the wound bed was covered with fibrin, which was strongly attached to the wound bed. Isolated granulation islands appeared. A wound odour was present when the dressing was removed. A wound swab was taken at first admission with the finding of colonisation by Corynebacterium sp. and coagulase-negative staphylococci. On 29.03.2016 a control smear was taken, in which only isolated erythrocytes, leukocytes and epithelial cells were found. The local therapeutic wound treatment in the WZ® Wound Centre was carried out as follows: Wound cleaning: Wet-dry phase with a wound cleansing solution based on a singlet oxygen, NaOCl (ActiMaris®). Wound filler: Tamponade with LIGASANO® Wound strip 300 x 2.5 x 0.4 cm, white, sterile. Wound coverage: Zetuvit® plus10 x 20 cm. Fixation with Mefix® 11 cm x 10 m. Frequency of dressing changes daily, with exudate removal 3-4 x weekly. Relatives were instructed on dressing changes. In the context of the reduction of patient relatives, particular emphasis was placed on hygienic measures, nicotine refusal, pain medication intake and nutritional substitution. A seat cushion was prescribed as an aid to reduce or distribute pressure. Fig. 1: 27.10.2015 Fig. 2: 17.11.2015 Fig. 3: 03.12.2015 Fig. 4: 22.12.2015 Fig. 5: 14.01.2016 Fig. 1: 27.10.2015: Wound size 8.37 cm2, wound depth 2.5 cm, pain according to NRS: 8/10 Fig. 2: 17.11.2015: Wound size: 4.35 cm2. Wound contraction visible, epithelial tissue in the wound area is stable. Wound depth: 1.8 cm. Due to the local therapeutic measure with the LIGASANO® wound dressing used, white, sterile, pain reduction could be achieved according to NRS: 3/6. Fig. 3: From 03.12.2015 a change in therapy was performed. Wound cleansing was left untreated, the absorber was replaced by a LIGASANO® wound dressing. Fixation remained. Frequency of dressing changes increased to 4x weekly. Fig. 4: 22.12.2015: Wound size 0.31 cm2, wound depth 0.1 cm, pain medication discontinued since 14.12.2015. Fig. 5: 14.01.2016: Stable, epithelialized wound, recurrence-free until August 2016. Summary / Conclusion: The LIGASANO® Wound Tape 300 x 2.5 x 0.4 cm, white, sterile shows a very good adaptation to the wound contours without exerting pressure on the wound. Granulation and wound contraction took place very quickly with simultaneous reduction of exudation and significant pain reduction. Author: Heidi Jodl, health and nurse, AZWM®, head of the WZ® Wound Center Augsburg (c) Ligamed Back to applications Back to products

PPE-Products Our articles are high-quality, certified products that guarantee protection and safety. Together for safety, because your health is important to us. Disposable gown nonwoven (40, 30, 25 gr) Non-sterile disposable gowns with long sleeves and elastic cotton cuffs. Lightweight disposable gown with belt at waist, closure at back neck with ties, eco-friendly material, soft and comfortable to wear. Non-woven fabric, comfortable, high quality and protective. Water-repellent, airy, odorless Comply with EN 13795-1:2019 Type II standard Medical product according to 93/42/EEG To the shop Zurück zu PPE Produkte Zurück zur Produktübersicht

PPE-Products Our articles are high-quality, certified products that guarantee protection and safety. Maintaining safety together, because your health is important to us. Hautfreundliches Händedesinfektionsmittel FFP2 masks without filter Hautfreundliches Händedesinfektionsmittel FFP3 masks without filter Hautfreundliches Händedesinfektionsmittel Face shield Hautfreundliches Händedesinfektionsmittel Gowns Hautfreundliches Händedesinfektionsmittel Suits Hautfreundliches Händedesinfektionsmittel Hoods Hautfreundliches Händedesinfektionsmittel Shoe covers, gloves Hautfreundliches Händedesinfektionsmittel Surgical masks Back to products

International events EWMA 2023 Video Camera EWMA 2023 by Ligamed Contact us Thank you for your message Send

Curea P2 P2 Curea P2 Gentle on the wound surface for atraumatic dressing changes With an integrated wound spacer grid, curea P2 is the soft alternative for exuding wounds with fresh granulation tissue, sensitive wound surrounding skin and burns. curea P2 is particularly suitable for slightly to heavily exuding wounds where the sensitive wound surface should be protected. The integrated wound spacer grid prevents sticking to the wound and reduces pain during dressing changes. Integrated 3D wound spacer grid does not stick to the wound and allows for atraumatic dressing changes SuperCore® ensures secure binding of excessive exudate Proven binding and reduction of germs and MMPs Proven binding of whole blood Core remains stable during application High absorption even under compression and pressure Reduced risk of wound maceration Breathable back side creates a well-balanced, moist wound healing environment Protection against leakage Printed back side for reduced risk of false application Wear time up to 7 days Indicatino for use: Intended for light to heavy exuding wounds Granulating wounds Burns Postoperative wound care Mesh graft and skin removal sites Sensitive wound environment Epidermolysis Bullosa Frostbite Chemical burns IFU P1 Curea P2 Instruction for use Back to Curea Back to products